Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v3-FR
Language English French
Date Updated 2022-09-22 2022-06-30
Drug Identification Number 02498537 02498537
Brand name ADYNOVATE ADYNOVATE
Common or Proper name Antihemophilic Factor (Recombinant), Pegylated Antihemophilic Factor (Recombinant), Pegylated
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients ANTIHEMOPHILIC FACTOR ANTIHEMOPHILIC FACTOR
Strength(s) 250UNIT 250UNIT
Dosage form(s) POWDER FOR SOLUTION KIT POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2 mL Vial 2 mL Vial
ATC code B02BD B02BD
ATC description VITAMIN K AND OTHER HEMOSTATICS VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-06-30 2022-06-30
Actual start date 2022-06-30 2022-06-30
Estimated end date 2022-09-30 2022-09-30
Actual end date 2022-09-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments